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Abstract 
Background: The impact that communication has on adherence, considering outcomes such as patient satisfaction and recall of the content of encounters with 
health care providers, has been extensively reported on in the literature. The South African Depression and Anxiety Group (SADAG) developed a specific com-
munication intervention program, which was implemented in a local public sector setting. Objective: To investigate the attendance and medication adherence 
of patients at the specialist psychiatric outpatient clinic of the Helen Joseph Hospital in Johannesburg, before and after the pilot implementation of this program. 
Methods: Included quantitative and qualitative methodologies. The retrospective component included a review of participants’ demographic and clinical pro-
file and medication adherence. The prospective, qualitative component included structured pre- and post-questionnaires. Results: The typical participant was 
female (76%), older than 40 years (58.2%) and unemployed (74.2%). Comparing the study and control groups, the communication program resulted in a higher 
post-intervention booking ratio for the Study group, while the diagnostic category of participants were associated with their understanding of their medica-
tion. Discussion: Being mindful of the noted limitations of this pilot project, the SADAG program or similar communication intervention strategy, should be 
a standard operational procedure in local South African state sector clinics.
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Introduction
The terms “adherence” and “compliance” have been used interchange-
ably in different settings. Vermeire et al. noted that “compliance” is 
considered to have negative associations and suggests yielding or 
submission: “Compliant patients ‘submit’ to the prescriptions of doc-
tors and take their medicine, or follow their advice, a phrase that also 
means accepting punishment”1. In contrast, “adherence” incorporates 
the broader notions of concordance (agreement and harmony), 
cooperation and partnership. For its 2001 “Adherence to Long-term 
Therapies Project”, the World Health Organization (WHO) defined 
adherence as “the extent to which a person’s behaviour of taking 
medication, following a diet, and/or executing lifestyle changes, cor-
responds with agreed recommendations from a health care provider”2. 
In addition, the term “retention” which refers to the capacity to retain 
patients in active participation, has also been used recently in the 
context of the substance abuse treatment by, for example, Baltieri and 
Corrêa Filho3. In this regard, several client-centered factors (such 
as being younger, single social status and family alcoholism) and 
treatment-centered factors (such as a negative therapeutic alliance 
and inadequate engagement of family) have been associated with 
early discontinuation of alcohol abuse treatment with high rates of 
treatment abandonment and relapses during follow-up4.
The impact that communication has on adherence, considering 
outcomes such as patient satisfaction and recall of the content of 
encounters with health care providers, has been extensively reported 
on in the literature. While Ley already commented on the relationship 
between communication and the outcome of treatment programs 
during the 1970’s5, Simpson et al. reported in the early 1990’s on it, 
in terms of the “Toronto Consensus Statement”6. They noted that 
effective communication between doctor and patient is a central 
clinical function which cannot be delegated. Zolnierek and Dimat-
teo conducted a meta-analysis of published literature (1949 to 2008), 
using a random effects model7. They found physician communica-
tion to be significantly associated with patient adherence, with a 
19% higher risk of non-adherence among patients whose physicians 
communicated poorly. They also reported that training physicians 
in communication skills resulted in substantial and significant im-
provements in patient adherence. Sanson-Fisher et al. also noted that 
effective communication skills can and should be taught to health 
care providers as part of their training8. In their qualitative review of 
the medical literature from 1970 to 2005, Jin et al. reported on fac-
tors affecting therapeutic adherence from the patient’s perspective9. 
They identified patient-centered factors, therapy-related factors, 
socio-economic factors and patient-centered factors, with the latter 
including the patient-prescriber relationship and communication 
which, in particular, also had a significant effect on compliance. 
Helen Joseph Hospital (HJH) in Johannesburg, South Africa, is 
a public sector regional referral hospital providing secondary and 
tertiary levels of care. Psychiatric services at the hospital consist of a 
30-bed acute admission unit, as well as of consultation-liaison service 
and a specialist psychiatric out-patient clinic. As far as adherence of 
psychiatric in-patients is concerned, it was previously documented 
that 40-45% of patients routinely admitted, reported that they were 
non-adherent with their prescribed treatment prior to admission10-12. 
Due to the continuous re-admission of the same patients and to 
logistical problems at the clinic, it also became necessary to explore 
the extent to which patients at the HJH psychiatric out-patient clinic 
have an inadequate understanding of their maintenance care. In 
this context, it was proposed to collaborate with a prominent local 
advocacy group, the South African Depression and Anxiety Group 
(SADAG), to implement a communication intervention program on 
a pilot basis, and to assess its usefulness to improve adherence in this 
local public sector setting. SADAG is a non-profit, non-governmental 
organization established 18 years ago to provide a mental health care 
support network to users across South Africa. SADAG works closely 
with different groups of people with mental health related problems on 
an on-going basis, and became increasingly aware of the problem of 
non-adherence with medication and follow-up visits to care providers. 
Also considering the impact that communication has on adher-
ence, as emphasized by others, SADAG, in response, developed a 
communication intervention program, the “Reminder and Support 
Adherence Program” (RSAP), which was previously implemented 
in certain private practice settings. The RSAP consists of focused 
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communication interventions, including: weekly phone calls; free 
telephonic counseling; reminder SMS-messages; brochures and 
information; SMS reminders for workshops, support groups and 
press notifications; an online website with information; monthly 
newsletters; and free support groups in different regions. 
The purpose of this study was to investigate the attendance and 
medication adherence of patients for the maintenance of various psy-
chiatric conditions at the HJH specialist psychiatric outpatient clinic, 
before and after the pilot implementation of specific communication 
interventions, using the SADAG RSAP. The objectives of this study 
were to: explore the basic knowledge and understanding of patients’ 
conditions and treatment prior to the implementation of the proposed 
communication intervention program; implement the communica-
tion intervention program (RSAP) for an initial period of three 
months; document the experience and views of participants after 
the implementation of the RSAP; and compare medication and clinic 
attendance adherence at baseline and after the RSAP intervention.
Methods 
The methods used included quantitative and qualitative methodolo-
gies. The retrospective, quantitative component included a review 
of participating patients’ demographic and clinical profile and 
medication adherence prior to the intervention, in June 2012. The 
quantitative data was collected from the clinical records and variables 
reviewed included: age; gender; ethnicity; suburb; attendance of the 
previous booked clinic appointments; diagnoses; and prescribed 
treatment. Using Microsoft Excel (97-2013), descriptive statistical 
methods, including means and standard deviations for parametric 
variables, were used to analyze these variables. The prospective, 
qualitative component of the inquiry included: (1) a structured pre-
questionnaire exploring patients’ basic knowledge and understanding 
of their conditions and treatment (Addendum 1); (2) the three-month 
(July to September 2012) implementation of the structured SADAG 
RSAP; and (3) a structured post-questionnaire, exploring patients’ 
experience to participate in the RSAP and of their subsequent un-
derstanding of conditions and treatment (Addendum 1). 
Addendum 1
SADAG RSAP* PRE-QUESTIONNAIRE – KNOWLEDGE AND UNDERSTANDING OF 
CONDITIONS AND TREATMENT
1. DEMOGRAPHIC INFORMATION
1) Age; 2) Gender; 3) Race/Ethnic Group; 4) Marital Status; 5) Employment Status
2. CLINIC ATTENDANCE AND DIAGNOSTIC INFORMATION
6) Have you been to any other psychiatric clinic or hospital before?
7) Were you treated as an INPATIENT or OUTPATIENT?
8) Have you been to the Helen Joseph Psychiatric Unit/Outpatients before?
9) Were you treated as an INPATIENT or OUTPATIENT?
10) Do you know what you have been diagnosed with? 
11) How often do you have to return to outpatients to see the doctor in the 
next 3 months?
3. MEDICATION ADHERANCE¹ 
12) Do you know what medication that you receive from HJH Psychiatric 
Outpatient Clinic? 
13) Do you know how often to take it and how many of the tablets at a time?
14) If you are unsure, what is it that you need to know about your 
medication?
15) When did you start to take your medication from Helen Joseph?
16) Are you able to take your medication as suggested by your doctor?
17) If NO, please give a reason why not? 
18) Are you sometimes using alcohol or other substances, like cannabis, 
while also on medication?
19) Did the doctor explain to you how to take your medication? 
20) Are you having any side-effects from your medication? 
21) Are you currently making use using any support services such as?
¹ Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure 
of medication adherence. Med Care. 1986;24(1):67-74. * SADAG: South African Depression and 
Anxiety Group; RSAP: Reminder and Support Adherence Program.
SADAG RSAP* POST QUESTIONNAIRE – EVALUATION OF THE PROGRAM
1. RSAP IMPLEMENTATION 
1) Did you receive the SMS reminders to take your medication?
2) Did you receive the SMS reminders to attend your next hospital visit?
3) Did you receive the telephone phone calls from a SADAG counsellor?
4) Did you find these calls helpful?
5) Did you receive the information brochure on your mental health condition?
6) Did you find the information brochure useful?
7) Did you attend the clinic when you were scheduled to do so?
8) Did you make use of the SADAG support group services suggested?
9) Were these SADAG support groups useful to you?
2. POST-PARTICIPATION ADHERENCE
10) Did you perhaps stop taking your medication for any reason?
11) Did you skip any of your medication doses?
12) Did you attend all your scheduled hospital appointments?
3. EVALUATING THE RSAP 
13) Following the RSAP support program, do you now have a better 
understanding of your condition?
14) Following the RSAP support program, do you now have a better 
understanding of your medication?
15) How did you generally experience the SADAG RSAP support program? 
16) Which part of the SADAG RSAP support program was the most helpful to you?
17) Which part of the SADAG RSAP support program was not helpful to you?
18) What can be done to make the SADAG RSAP support program more helpful?
19) Can you describe how the SADAG RSAP support program was useful in 
helping you to stay on your medication?
20) Can you describe how the SADAG RSAP support program was useful in 
helping you to attend your visits to the doctor at the clinic? 
21) Can you describe how the SADAG RSAP support program was useful in 
helping you to collect your medication from to the pharmacy, or to go to the 
laboratory for tests?
22) Can you describe how the SADAG RSAP support program was useful in 
informing you about different mental health issues, conditions and treatment?
* SADAG: South African Depression and Anxiety Group; RSAP: Reminder and Support Adherence 
Program.
The sampling method used for recruiting participants in the 
questionnaires and the pilot communication intervention program 
was convenience sampling through an open invitation to clinic at-
tendants while waiting for their doctors’ appointment on subsequent 
clinic days during July to September 2012. No particular inclusion or 
exclusion criteria were set. Implementing the RSAP pilot program 
consisted of regular phone calls, as well as the other mentioned 
communication interventions. Completion of the questionnaires 
occurred during a personal discussion while waiting for their doctors’ 
appointment, or if preferred, by telephone using a toll free SADAG 
line. Qualitative answers to more open-ended questions were ana-
lyzed using a content analysis approach by thematic coding of the 
written/transcribed verbal responses by participants.
The pre-questionnaire included items on: demographics (Ques-
tions 1-5), clinic attendance (Questions 6-11); and diagnosis and 
medication adherence (Questions 12-21). The medication adherence 
questions included were drafted while also considering the items from 
the Morisky 8-Item Medication Adherence Questionnaire13. During 
the study period, participants received logistical, psycho-educational 
and support interventions in terms of the RSAP over the following 
three months, according to a structured alert schedule and accord-
ing to participants’ preferences as indicated on the consent form. 
Access to psycho-educational information included the standardized 
SADAG Board approved brochures on major depression, bipolar 
mood disorder, anxiety disorders, schizophrenia, and substance use 
disorders. The post-intervention questionnaire was conducted after 
the three-month implementation period and included items on: the 
RSAP implementation (Questions 1-9); post-participation adherence 
(Questions 10-12); as well as evaluating the RSAP (Questions 13-22). 
The study group was compared at baseline with a control group 
with regard to demographic, clinical and attendance profile. The 
control group consisted of randomly selected outpatients not par-
ticipating in the RSAP. After the RSAP intervention, the groups were 
compared again with regard to their attendance during the subsequent 
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six months. Pre-intervention, the following data was collected for 
both groups: age; gender; diagnostic category; and their six-month 
booking ratio during January to June 2012 (number of visits attended/
number of visits scheduled), while responses to questions relating to 
knowledge of medication and medication adherence were collected for 
the study group only from the pre-questionnaire. Post-intervention, 
data were collected on the groups’ subsequent six-month booking 
ratios during July to December 2012; and, for the study group only, 
responses to questions relating to medication adherence and clinic 
attendance (from the post-questionnaire at three months after start of 
intervention). The study group itself was compared before and after the 
intervention with regard to the booking ratio and medication adhe-
rence. Within the study group, the relationship between age, gender, 
diagnostic category and booking ratio was assessed, as well as between 
selected measures in the pre- and post-intervention questionnaires. 
Data analysis was carried out using SAS14. Between-group tests 
were conducted using the Χ2 test to assess the relationships between 
categorical variables. Fisher’s exact test was used for 2 x 2 tables or 
where the requirements for the Χ2 test could not be met. The relation-
ship between continuous and categorical variables was assessed by the 
t-test (or ANOVA for more than two categories). Where the data did 
not meet the assumptions of these tests, a non-parametric alternative, 
the Wilcoxon rank sum test (or the Kruskal-Wallis test for more than 
two categories) was used. The relationship between two continuous 
variables was assessed by Pearson’s correlation coefficient. Where the 
data did not meet the assumptions of these tests, a non-parametric alter-
native, Spearman’s rank correlation coefficient was used. Within-group 
tests for paired booking ratio data were carried out using the Wilcoxon 
matched pairs test. The 5% significance level was used throughout. 
Ethical clearance for the study was obtained from the University of 
the Witwatersrand Human Research Ethics Committee. Information 
leaflets, consent forms and questionnaires were also translated into 
Afrikaans and isiZulu. Data obtained was analyzed and reported on 
anonymously and in a manner that doesn’t allow for individual partici-
pants to be identified or recognized. In terms of the Mental Health Care 
Act15, all patients at the HJH psychiatric outpatient clinic at the time of 
the study were voluntary users, and therefore considered to have the ca-
pacity to make an informed decision about their own mental health care 
and also to give personal informed consent to participate in this inquiry. 
Results
Out-patients during January to June 2012 
The total number of active psychiatric out-patients in June 2012, prior 
to the implementation of the RSAP, was 607. From these, a group of 
91 patients (15%) was recruited to participate in the three-month 
implementation of the communication intervention program (RSAP), 
as well as in the pre- and post-questionnaires. Nobody who was ap-
proached declined, and recruitment continued until data saturation 
was achieved for the qualitative components of the questions included.
Demographic, clinical and geographic profile of RSAP 
participants
Participants included more females 76% (n = 69) than males 24% (n 
= 22), with a ratio of 3.1 to 1. The race distribution of participants was 
Black 34% (n = 31), White 35% (n = 32), Coloured 22% (n = 20) and 
Indian 9% (n = 8). The age of participants ranged from 17 to 73 years, 
with the mean age 41.9 years and a standard deviation of 13.95. While 
nearly two thirds (58.2%; n = 53) were older than 40 years, about a 
third (28.6%; n = 26) was between 40 and 49 years. More than two 
thirds (64.8%) of participants spoke English, with Afrikaans the second 
most common spoken language (19.8%). The remaining 15.4% (n = 14) 
spoke an African language (isiZulu). In terms of relationships, 39% (n 
= 36) participants were single, 29% (n = 26) were married, 13% (n = 
12) divorced, 9% (n = 8) widowed, 9% (n = 8) were in a relationship at 
the time and one was engaged. More than two thirds (61.5%; n = 56) 
were not in a relationship with a partner at the time (single, divorced 
or widowed). The majority of participants (75%) were unemployed, 
and of the quarter of those who were employed (n = 23), 69.6% were 
working full-time (n = 16), and 30.4% part-time (n = 7). Of those 
who were in full-time employment, most of them 68.8% (n = 11) had 
to take the day off from work to attend the clinic. Table 1 provides a 
summary of participants’ DSM IV-RT diagnoses and categories of 
medication16. Major depressive episode/disorder was the most com-
mon diagnosis (22%) documented for participants, followed by bipolar 
mood disorder (13.2%), anxiety disorders (9%) and psychosis due to 
general medical conditions (9%), for most participants (89%) more 
than one medication per patient were usually prescribed. The catego-
ries of medication prescribed for this group of patients at this state 
sector specialist psychiatric outpatient clinic, included: antidepressants 
(57%); antipsychotics (56%); mood stabilizers (38.5%); anxiolytic/
sedative medication (31.8%); and other general medical treatment 
(17.6%). Most of the participants were from the Inner City region of 
Johannesburg – Region F (n = 34; 37.8%), while most of the others 
resided in Region B – Northcliff/Randburg (n = 22; 24.4%), Region 
D – Greater Soweto (n = 17; 19%) and Region C – Roodepoort (n = 
8; 8.9%), figure 1. Three each were from Regions A, E and G and one 
participant resided outside the Johannesburg regional area. 
Table 1. Participants’ most common DSM IV-RT diagnoses and categories 
of medication
AXIS I – Major depressive episode/disorder (n = 20; 22%); bipolar mood disorder 
(n = 12; 13.2%); anxiety disorders (n = 8; 9%) and psychosis due to general 
medical conditions (n = 8; 9%)
AXIS II – Total n = 21: Cluster B or borderline personality traits (n = 14); 
intellectual impairment (n = 4); Cluster C or dependent personality traits (n = 3)
AXIS III – Documented for 48 participants: HIV/AIDS (n = 14); hypertension (n 
= 13); epilepsy (n = 9); diabetes mellitus, ischemic heart disease and metabolic 
syndrome (n = 5); neuro-syphilis (n = 2); and other (breast cancer n = 1; Parkinson’s 
disease n = 1; Prader-Willi syndrome n = 1; head injury, n = 1; and stroke n = 1)
TREATMENT – Antidepressants (n = 52; 57%); antipsychotics (n = 51; 56%); 
mood stabilizers (n = 35; 38.5%); anxiolytics/sedative medication (n = 29; 31.8%) 
and other general medical treatment (n = 16; 17.6%); for most participants (n = 
81; 89%) more than one medication were prescribed
KEY: Region A – Diepsloot, Midrand, Fourways, Sunninghill, Woodmead; Region B – 
Rosebank, Bryanston, Randburg; Region C – Bram Fischer, Thulani, Florida; Region D 
– Soweto; Region E – Parkwood, Highlands North, Alexandra, Wynberg, Morningside, 
Douglasdale; Region F – Glen Vista, Ormonde, City Deep, Benrose, Kensington; Region 
G – Lenasia, Eldorado Park, Protea.
Figure 1. Johannesburg Regional Map (www.joburg.org.za; Accessed 14 
January 2013).
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Pre-intervention questionnaire  
Prevailing knowledge about clinic visits, diagnosis and treatment
Only 6.6 % (n = 6) of the 91 participants stated in their response to 
Question 10 that they did not know what their diagnosis was, while 
only 5.5% (n = 5) patients said they did not know how often they have 
to attend the clinic (Question 11). Table 2 summarizes participants’ 
responses to selected items of the pre-intervention questionnaire 
(Questions 12-21). 
10 with bipolar mood disorder, 7 with schizophrenia and for 2 the 
diagnosis was not specified. For 5 of these participants no informa-
tion was available. While only 17 participants actually volunteered 
that they were non-adherent, 60 of the 74 who indicated that they 
actually were adherent, did however give reasons for non-adherence 
to medication in the follow-up question (Question 17). 
Reasons for non-adherence with medication (Question 17)
The most common reason indicated in response to this question was 
forgetfullness (28.6%; n = 26), or that they did not have anybody to 
remind them (24.2%; n = 22), figure 2. Participants also cited more 
than one reason for non-adherence to medication, which explains the 
difference in total number of responses. Only 12 (13%) reported that 
the reason for their non-adherence was in fact because of perceived 
adverse reactions of the medication, while 11% reported that medica-
tion was not available at the pharmacy. One in ten participants (10%) 
indicated that they felt they did not need medication. 
Table 2. Participants responses to SADAG RSAP* Pre-Questionnaire’s 
medication adherence items (n = 91)
Question 12. Do you know what medication that you receive from HJH 
Psychiatric Outpatient Clinic? 
YES n = 77; 84.6% NO n = 14; 15.4%
Question 13. Do you know how often to take it and how many of the tablets at 
a time? 
YES n = 74; 81.3% NO n = 17; 18.7%
Question 14. If you are unsure, what is it that you need to know about your 
medication? 
YES n = 27; 29.7%; on: potential 
adverse effects from the medication 
(n = 16); efficacy (n = 6), and dosage 
(n = 5) 
NO n = 64; 70.3%
Question 16. Are you able to take your medication as suggested by your doctor? 
YES n = 74; 81.3% NO n = 17; 18.7%
Question 18. Are you sometimes using alcohol or other substances, like 
cannabis, while also on medication?
YES n = 35; 38.5% (cigarettes n 
= 21, 60%; alcohol n = 8, 22.8%; 
paracetamol n = 3, 8.6%; cannabis n 
= 3, 8.6%)
NO n = 56; 61.5%
Question 19. Did the doctor explain to you how to take your medication?
YES n = 80; 87.9% NO n = 11; 12.1%
Question 20. Are you having any side-effects from your medication?
YES n = 73; 80.3% NO n = 18; 19.7%
Question 21. Are you currently making use using any support services such as?
YES n = 31; 34.1% NO n = 60; 65.9%; but sought spiritual 
or religious support (n = 11) or other 
counselling (n = 10)
* SADAG: South African Depression and Anxiety Group; RSAP: Reminder and Support Adherence 
Program.
Knowledge of medication (Questions 12-14)
Of those (n = 77) who knew what medication they were supposed 
to take, when and how, 22 were diagnosed with major depressive 
disorder, 21 with psychosis due to general medical condition, 14 
with anxiety, 12 with bipolar mood disorder, 7 with schizophrenia 
and for 2 the diagnosis was not specified. 
Adherence to medication prior to RSAP (Question 16)
In terms of responses to this question, about 80.0% of the patients 
reported that they were taking their medication as suggested by 
their doctor. Seven of the self-reported non-adherent patients (n 
= 17) were diagnosed with major depressive disorder, four with 
psychosis or mood disorder due to a general medical condition, one 
each with schizophrenia and bipolar mood disorder and two with 
anxiety/personality problems or substance abuse. For two partici-
pants the diagnosis were not specified. Of the remainder, those who 
self-reported that they were actually able to take their medication as 
prescribed (n = 74; 81.3%), 18 were diagnosed with major depressive 
disorder, 19 with psychosis or mood disorder due to a general medical 
condition, 13 with anxiety/personality problems or substance abuse, 
Figure 2. Reasons for medication non-adherence of HJH psychiatric out-
-patients in SADAG RSAP, Jul-Dec 2012 (n = 77).
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Co-morbid substance abuse (Question 18)
Only a third of participants (31.4%; n = 11) were admitting to 
alcohol and cannabis use while they were being followed up as out-
patients during this period. 
Understanding of purpose and function of medication (Question 19)
About two thirds (62.6%; n = 57) of participants confirmed that 
their doctor explained to them any possible adverse reactions they 
might have, while only 21.9% (n = 20) said that their doctor explained 
to them how to cope with these possible adverse reactions.
Reported adverse effects of medication (Question 20)
Although all those who have self-reported perceived adverse 
reactions indicated that they have experienced more than one 
adverse effect, it was noted that despite of this, only 12 (13%) indi-
cated adverse side effects of medication as a reason for medication 
non-adherence. The most common adverse effect reported was 
having headaches (13%), while fewer experienced having a dry 
mouth (11.6%), poor sleep (11%), and an increased appetite (10.4%). 
146 Rensburg BJ et al. / Arch Clin Psychiatry. 2014;41(6):142-9 
A decreased appetite was mentioned as the fifth most common ad-
verese reaction (7.8%). At this stage, prior to the 3-month RSAP, two 
thirds (n = 48; 66%) of those who reported side effects, stated that 
they were, however, coping fine with the reported adverse reactions, 
while 19.2% (n = 14) said they were trying to cope and 15.1% (n = 
11) said they were not coping very well. 
Implementing the RSAP
Phone calls 
During the RSAP intervention, a total of 642 personal phone calls 
were made according to the described specified structured alert 
schedule, with each participant receiving and average of 7.3 calls 
during a 13 week (91 day) period.
Additional communication activities 
The communication activities (SMS reminders and other no-
tifications) which occurred during the RSAP were summarized in 
table 3. All the reminders and notifications included the SADAG 
toll-free helpline number. Monthly electronic newsletters were also 
made available to patients, however, only 35.2% (n = 32) had access 
to internet or email to receive this intervention. As noted, these ad-
ditional communication activities included: short message system 
(SMS) notifications; medication reminders; motivational SMS mes-
sages; support group notifications; press notifications; appointment 
and script reminders; and brochures/information.
11.4% (n = 10) of participants after the intervention indicated that 
they skipped doses of their medication during their participation in 
the RSAP. The majority 88.6% (n = 78) now indicated that they took 
their medication as prescribed by their doctor. None of the patients 
indicated that they have stopped taking their medication completely. 
While all participants indicated afterwards that they had a bet-
ter understanding of their medication, some did report limitations 
which included problems with obtaining and reading the educa-
tional material. Reasons for this were stated to be cost related (e.g. 
recommended magazines), access to internet, or their own literacy 
in English. Although patient information and questionnaires for 
this study were translated into Afrikaans and Zulu, the SADAG 
educational material on diagnoses and treatment was available only 
in English. In addition, radio and TV programs were reported to be 
helpful. In terms of the improvement of attending support group 
activities, for example, prior to the RSAP intervention the majority 
of the patients (65.9%) were not actually making use of any other 
additional mental health support services, and only 4.6% were at-
tending a support group (pre-questionnaire). After the program, 
about 10% of participants reportedly attended at least one session 
at a support group during the study period. Qualitative themes from 
the post-questionnaire included participants’ stated reasons for this 
non-attendance of support groups as being logistical (not having 
transport) 44%, and financial problems (32%). In terms of evaluat-
ing the design, incorporated items and the actual implementation 
of the SADAG RSAP, the increased regular communication through 
telephone calls and SMS reminders, as well as the additional logisti-
cal assistance provided, were regarded by all participants as to have 
been of great value to them. The SMS messages in particular were 
identified as most helpful as reminders to take medication, while the 
telephone calls were appreciated as participants had the experience 
that they “were not alone”, that “someone was there for them” and 
that “someone cared”.
Table 3. Communication activities during the implementation of the RSAP
Average received per 
participant
Total received by all 
participants
Medication Reminders 39.6 3484
Motivational SMS 14.1 1238
Support Group 
Notifications
2.1 182
Press Notifications 2.4 208
Appointment Reminders 3 265
Script Reminders 3 265
Brochure/Information 
Reminders
3 182
Post-intervention questionnaire  
Of the 91 participating users who initially completed the pre-
intervention questionnaire, 88 completed the full 3-month RSAP 
program. Regarding the three who were withdrawn, one participant 
was referred to a different outpatient facility closer to her residence, 
while another went abroad for nearly half of the program. A third par-
ticipant did not have a mobile phone for the duration of the program 
and were therefore not included, as she was unable not receive the 
reminder messages. The SADAG RSAP post-questionnaire included 
items on: the RSAP implementation (Questions 1-9 – medications 
reminders, appointment reminders, phone calls, information and 
brochures, support group attendance); post-participation adher-
ence (Questions 10-12 – medication adherence, support group 
attendance); as well as evaluating the RSAP (Questions 13-22 – 
post-participation understanding of diagnosis and medication). 
Table 4 summarizes participants’ responses to selected items of the 
post-intervention questionnaire. 
According to responses to post-intervention Questions 10 and 
11, 98.6% of the patients reported that they did not stop taking 
their medication for any reason, nor did they skip any doses. Only 
one patient did not answer the first question and was ‘unsure’ about 
the second. In terms of medication adherence (Question 11), only 
Table 4. Participants responses to the SADAG RSAP* Post-Questionnaire 
(n = 88)
1. RSAP IMPLEMENTATION 
Question 1. Did you receive the SMS reminders to take your medication?
YES n = 88; 100% NO n = 0; 0%
Question 2. Did you receive the SMS reminders to attend your next hospital 
visit?
YES n = 71; 80.6% (always); n = 17, 
19.4% (sometimes)
NO n = 17; 19.3%
Question 3. Did you receive the telephone phone calls from a SADAG 
counsellor?
YES n = 84; 95.5% (always) NO n = 4; 4.5% (sometimes)
Question 5. Did you receive the information brochure on your mental health 
condition?
YES n = 88; 100% NO n = 0; 0%
Question 8. Did you make use of the SADAG support group services suggested?
YES n = 9; 10.2% NO n = 79; 89.8%
2. POST-PARTICIPATION ADHERENCE
Question 11. Did you skip any of your medication doses? 
YES n = 10; 11.4% NO n = 78; 88.6%
Question 12. Did you attend all your scheduled hospital appointments?
YES n = 84; 95.5% NO n = 4; 4.5%
3. EVALUATING THE RSAP 
Question 13. Following the RSAP support program, do you now have a better 
understanding of your condition?
YES n = 88; 100% NO n = 0; 0%
Question 14. Following the RSAP support program, do you now have a better 
understanding of your medication?
YES n = 71; 80.7% ; n = 4; 4.5% 
(somewhat)
NO n = 13; 14.8%
* SADAG: South African Depression and Anxiety Group; RSAP: Reminder and Support Adherence 
Program.
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Comparisons between study and control groups
Of the 88 participants completing the RSAP, data on clinic attendance 
during January to June 2012 was available for 70. Data was collected 
for this group as the “Study group”, which was then compared with 
a randomly selected “Control group” of 70 patients who attended 
the HJH out-patient clinic during both six month periods, but did 
not participate in the RSAP. At the 5% significance level, assum-
ing a power of 80% and using small, medium and large effect sizes 
(d = 0.3, 0.5 and 0.8 respectively), sample sizes of 94, 35 and 15, were 
required respectively. The sample size of 70 used for this study was 
thus regarded adequate for the detection of only fairly large effect 
sizes (up to d = 0.35).
Study group and Control group at baseline (pre-intervention)
 Age – There was no significant difference in the median age 
between the two groups (Wilcoxon rank sum test: p = 0.53). 
For further analysis, age was grouped in 17 to 29 years, 30 
to 39 years, 40 to 49 years and older than 50 years, with also 
no significant between-group difference (chi-square test: 
p = 0.63).
 Gender – A significant difference was shown for the gender 
composition of the Study and Control groups (Fisher’s exact 
test: p = 0.017; phi coefficient = 0.22). The proportion of males 
in the Study group (21.4%) was significantly lower than those 
in the Control group (41.4%).  
 Diagnostic category – Considering the required DSM IV-
TR criteria, the two groups were organized in six categories: 
depressive disorders (e.g. major depression, dysthymia); 
bipolar mood disorder; psychotic disorders (schizophrenia, 
schizo-affective disorder and not specified); general medical 
conditions related disorders (psychosis, mood), as well as 
dementia and intellectual impairment; anxiety disorders, 
substance related disorders and conditions, as well as perso-
nality related problems; and lastly “no diagnosis” (Figure 3). 
No significant between-group difference was found (chi-s-
quare test: p = 0.054).
 Booking ratio – Where no appointments were scheduled 
for a participant, it was not possible to compare the booking 
ratio. In the pre-intervention period, this only affected three 
patients in the Study group, while many patients in the Con-
trol group were affected, as they only started attendance in 
the second half of 2012. Of a total of 90 appointments made 
pre-intervention for 44 patients in the Control group, 63 
appointments were kept (70%). Of a total of 157 appoint-
ments made for 67 patients in the Study group during the 
same period, 120 appointments were kept (76%). Booking 
ratio data were available for 67 of 70 of the Study group, but 
only for 44 of 70 of the Control group. At baseline, there was 
no significant difference found in the median booking ratio 
between the two groups (Wilcoxon rank sum test: p = 0.94).
Study group and Control group after intervention 
 Booking ratio – Booking ratio data for the post-intervention 
period was available for all the patients (Figure 4). Of a total of 
124 post-intervention period appointments made for 70 pa-
tients in the Control group, 82 appointments were kept (66%). 
Of a total of 209 post-intervention period appointments 
made for 70 patients in the Study group, 155 appointments 
were kept (74%). Considering the post-intervention period 
booking ratio as a function of group (Study/Control) while 
controlling for the pre-intervention period booking ratio, the 
post-booking ratio is expected to differ between groups if 
there is a group effect. While taking the limitation of missing 
data at pre-intervention for the control group into account, 
this model has been shown to be significant with n = 111; F 
(2,108) = 4.73, and p = 0.011, while the effect of group was also 
significant (p = 0.0084). Controlling for the pre-intervention 
booking ratio, the Study group demonstrated a higher post
-intervention period booking ratio (by 0.17) than the Control 
group. The effect of the pre-intervention booking ratio itself 
was not significant (p = 0.16). When considering the full 
data set, comparing the post-intervention period booking 
ratio between the two groups, no significant difference in the 
median booking ratio between the two groups was showed 
(Wilcoxon rank sum test: p = 0.89).
1 – Depressive disorders (e.g. major depression, dysthymia); 2 – Bipolar 
mood disorder; 3 – Psychotic disorders (schizophrenia, schizo-affective 
disorder and not specified); 4 – General medical conditions related disor-
ders (psychosis, mood), as well as dementia and intellectual impairment; 
5 – Anxiety disorders, substance related disorders and conditions, as well 
as personality related problems; 6 – No diagnosis.
Figure 3. Diagnostic category HJH psychiatric outpatients Study and Control 
groups at baseline prior to intervention (June 2012)
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Figure 4. Booking ratio HJH psychiatric outpatients: Study and Control 
groups after intervention (July to December 2012).
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Comparison of Study group before and after intervention   
For the 67 Study group patients who had pre-intervention and post-
intervention study group data, there was no significant change in the 
booking ratio between the two time periods (paired t-test; p = 0.76). 
A comparison of medication adherence before and after intervention 
was not possible because the question(s) used to determine medica-
tion adherence pre- and post-intervention were not the same. 
Factors associated with adherence
For the Study group, associations were examined between age, 
gender, diagnostic category and pre-intervention booking ratio, as 
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well associations between selected measures in the pre- and post-
intervention questionnaires. With regard to medication adherence, 
two sets of composite scores were calculated. Pre-intervention for this 
group, a composite score (Score A) was derived from Questions 12, 
13, 14 and 16 of the pre-questionnaire, such that “0” equaled a poor 
understanding of medication and “4” equaled a high understanding 
(Table 5). Post-intervention, a composite score (Score B) was derived 
from Questions 11, 12, 13 and 14, such that “0” equaled a poor un-
derstanding of condition/treatment/medication and “4” equaled a 
high understanding. A significant (lower) association was found for 
the Diagnostic category and the pre-intervention composite Score 
A (Kruskal-Wallis test; p = 0.044). Post-hoc tests showed that the 
Score A median for Category 6 – “No diagnosis” (median 0.5), was 
significantly lower than that for Categories 1 (Depressive disorders), 
2 (Bipolar mood disorder), 4 (General medical conditions related 
disorder) and 5 (Anxiety, Substance related and Personality disor-
ders) – median 4.0. These effect sizes were moderate, however, given 
that there were only two patients in Category 6, these results must be 
interpreted with caution. There were no other significant associations.
Table 5. HJH psychiatric outpatients Study Group composite scores for 
medication adherence pre- and post-intervention
p-value for H0: no 
association
Score A
Pre-intervention*
Score B 
Post-intervention#
Age category 0.34 0.15
Gender 0.20 0.10
Diagnostic category 0.044 0.68
Pre-intervention booking 
ratio
0.85 0.63
* Composite score compiled form Questions 12, 13, 14 and 16 of pre-questionnaire; # Composite 
score compiled from Questions 11, 12, 13 and 14 of post-questionnaire.
Discussion
Specific limitations of this pilot study include, firstly, that the sam-
pling method used did not result in a representative randomized 
sample, and secondly, as a partial retrospective study, data on all the 
demographic and clinical variables of users was not always available 
for all participants. Results from this sample can therefore not be 
extended to the total group of existing outpatients. However, despite 
the pilot nature of this investigation, certain useful statistical analyses 
of data were performed while the limitations in this regard were 
noted. In addition, the general problem of positive self-reporting 
when using self-rating scales must also be taken into account. The 
findings of this study may therefore have been influenced by overly 
positive self-reporting by a group of participants who, in this case, 
may have had “more adherent attributes” to gravitate towards more 
contact, compared to self-selected non-participants who, due to the 
extent of their symptoms and nature of their diagnosis, or existing 
non-compliance, may have been more reluctant to participant and 
more inclined to avoid additional contact with the clinic or caregivers 
at the clinic. Randomized and stratified representative sampling must 
therefore be considered in any future follow-up studies. In terms of 
the design of the questionnaires, in order to allow for comparisons 
to be made before and after intervention, the same questions inquir-
ing about medication and attendance adherence should have been 
included in the pre- and post-questionnaires. In fact, the use of a 
previously validated scale for measuring adherence should have been 
advised, rather than a questionnaire which only included some of 
the Morisky 8-item Medication Adherence Questionnaire (MAQ)13. 
Lastly, although all participants had mobile phones to receive SMS 
messages, another limitation was that not all had access to the internet 
to receive the monthly newsletters or educational material. 
Although the typical participant in the RSAP was female (76%), 
either Black (34%) or White (35%), older than 40 years (58.2%), unem-
ployed (74.2%), not in a relationship with a partner (67.6%) and mostly 
spoke English as home language (64.8%), Vermeire et al.1, as well as 
Yeğenoğlu et al.17, noted that demographic variables were poor indi-
cators of compliance. Another local study on medication adherence 
of psychiatric patients in an outpatient setting in KwaZulu-Natal18, 
using the 8-item Morisky MAQ, however, did find race and age to be 
significant predictors of medication adherence. While keeping in mind 
that the study by Bulloch and Patten was conducted in a large general 
Canadian population sample, it was noted though that the finding of 
this small pilot study in a local South African clinical setting, seems 
to concur with theirs, that “forgetting” was the most common reason 
reported (52.8%) for not being adherent with medication19.
Considering the pilot nature of this investigation, certain statistical 
analyses of data were performed and while limitations in this regard 
were noted, some observations were made including that significantly 
more females participated in this study compared with the Control 
group. It was also shown that the RSAP intervention resulted in a 
higher post-intervention booking ratio for the Study group compared 
with the Control group, and that the diagnostic category of partici-
pants were significantly associated with their understanding of their 
medication. In a comparable study, Heyscue et al. examined whether 
patients’ geographic location and socio-demographic characteristics 
and characteristics of their medication use were related to adherence 
with a long-acting injectable regimen in a group of outpatients with 
schizophrenia20. They found that compliance was associated with a 
history of substance abuse (poorer) and the duration of illness (better).
A possible explanation for the positive results found comparing 
the Study and Control groups may include that males were not effec-
tively targeted by the non-random, non-stratified sampling method 
used in this study. While there were no significant difference with 
regard to the attendance of booked visits between the Study and 
Control group before intervention, a significant difference was found 
between the two groups for attended visits after the three-month 
implementation of the RSAP. The finding that post-intervention the 
Study Group attended 74% of booked visits, compared to 66% by the 
non-participating Control Group seems to be a provisional indication 
that the RSAP did result in a relatively significantly improved booking 
ratio for participants in the program. This finding will however have 
to be confirmed in a longer term follow-up study. Negative results 
regarding changes pre- and post-intervention within the Study group 
include the finding that there was in fact no significant change in the 
booking ratio for the Study Group between the two time periods. 
This implies that the pilot implementation of the RSAP per se did not 
result in an improvement of the attendance rate of the participants in 
the program. The only other tentatively positive finding was the lower 
association found for the pre-intervention composite Score A and the 
sixth diagnostic category (“No diagnosis”) compared to four other 
diagnostic categories (1, 2, 4 and 5). As mentioned, because of the 
limited numbers, no actual significance have been attributed to this. 
This study at HJH also concurs with the review by Vermeire et 
al. that side-effects were only self-reported by a small proportion 
(10-15%) of patients as a reason for non-compliance1. Substance 
abuse as a contributing factor to non-adherence was relatively 
underreported in this study as well, although 30% of this clinically 
stable study sample reported that they concurrently used alcohol 
and/or cannabis with their medication (Question 20). Secondary 
non-adherence usually includes patients who are taking incor-
rect doses, or at wrong times, forgetting one or more doses of the 
medication, or who are stopping too soon, either by ceasing to take 
the medication, or by failing to obtain a repeat prescription due to 
unavailability, inaccessibility or cost. Participants in this study also 
reported “secondary” non-adherence, such as the unavailability of 
medication at the pharmacy, as well as stigma related reasons, such 
as doubting the efficacy of medication, or as a result of their percep-
tion about society’s negative view of psychiatric treatment. With 
regard to attitudes towards antidepressants, Castaldelli-Maia et al. 
noted for example, that stigma against depression differs from stigma 
against the use of antidepressants, with the latter seemingly more 
related to associations with emotional weakness and an inability to 
deal with problems21. Reviewing associations with the diagnosis of 
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schizophrenia in the Brazilian media, Guarniero et al., confirmed 
that texts from the printed media reviewed seem to still reinforce 
existing stigma by superficially referring to the diagnosis and by 
trivializing it out of context22.
Considering participants’ initial responses in this pilot study to 
questions regarding communication by doctors about their clinic vis-
its, diagnoses and medication (Questions 10, 11, 13 and 14), it seems 
that adequate communication was actually taking place in this regard. 
A somewhat contradicting response was observed regarding Ques-
tions 16 and 17, where only a relatively small proportion of responders 
(18.7%) volunteered non-compliance, while many more (65%) gave rea-
sons for non-compliance. This can be interpreted that non-adherence 
was actually much higher and that overly positive self-reporting could 
have influenced this finding. With regard to the effect on compliance 
with medication by patients experiencing adverse effects, it should also 
be considered to what extent patients reported real or perceived adverse 
effects as a result of medication use, or whether the symptoms reported 
may have been due to another cause. While 80.2% of participants in this 
study self-reported that they were experiencing adverse effects from the 
medication, only 13% has actually indicated this as a reason for non-
adherence to medication. This may also have been because participants 
wanted to portray a more positive picture of the actual situation. 
Considering the subjective qualitative responses from par-
ticipants to the post-questionnaire, as well as the pre- and post-
intervention booking ratios for the Study Group before and after 
the communication intervention program, it seems that the pilot 
implementation of the SADAG RSAP at HJH did result in some 
noteworthy improved adherence. While this may be encouraging, 
it may, however, also be argued that the improved clinic attendance 
observed, was not necessarily due to the specific design of the RSAP 
per se, but that any improvement on the pre-existing poor level 
and quality of communication at this clinic, would have motivated 
patients to attend better. The particular communication activities, 
relative to other, which would be most helpful in this state sector 
setting will therefore still have to be established more clearly through 
further follow-up study and comparison.
Conclusion
The partnership with a local mental health advocacy group to 
implement and investigate the effect of a particular communication 
intervention program in patients at a South African public sector 
psychiatric out-patient clinic, was a first attempt of this nature in 
the local context. Cognizant of the study’s listed limitations as a pilot 
investigation, and although further sophistication and specification 
may be required, the implementation of the SADAG RSAP, or a 
similar communication intervention strategy, should be considered 
as a standard operational procedure in all existing local state sector 
specialist psychiatric outpatients clinics, such as this clinic at HJH. 
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